SCOTUS decision in Hobby Lobby case reaches beyond contraception.
Results of the RECOURSE trial may make the combination agent a new standard of care in advanced disease.
Lung-MAP and the National Lung Matrix Trial aim to deliver precision-based, FDA-approved treatment to patients with lung cancer by using a streamlined trial design that allows flexibility for the investigators, patients, and drug manufacturers.
Inaccurate test results falsely classify some women as HER2 negative, denying them the benefits of targeted treatment.
Daily aspirin doses for cardioprotection also have a preventive effect against pancreatic cancer.
A study that included almost half a million mammograms suggests that tomosynthesis combined with digital mammography may become the new standard of care.
Matt Zibelman, MD, provides his view on the research presented during the plenary session at the 2014 ASCO Annual Meeting.
APC analogs can deliver a I-131 radiotherapy payload directly to tumor cells, or a fluorescent payload to help surgeons optimize margins during tumor resection.
An international study has revealed the potential of breathalyzer tests for detecting lung cancer with surprising accuracy.
Oral malignancies can be associated with increased pain, but current research suggests that a cannabis-based spray may reduce this morbidity.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|